Multipotent Mesenchymal Stromal Cell Therapy and Risk of Malignancies

Federica Casiraghi; Giuseppe Remuzzi; Mauro Abbate; Norberto Perico

doi:10.1007/s12015-011-9345-4

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2021

Mesenchymal Stromal Cell Therapy in Solid Organ Transplantation

Manuel Alfredo Podestà, Giuseppe Remuzzi, Federica Casiraghi

Article2019

Mesenchymal stromal cell-based therapy in kidney diseases and transplantation

Federica Casiraghi, Giuseppe Remuzzi

Article2016

Assessment of Multipotent Mesenchymal Stromal Cells in Bone Marrow Aspirate From Human Calcaneus

Chunmei Li, Cory D. Kilpatrick, Shannon S. Kenwood, Dean L. Glettig, Douglas J. Glod, Jason P. Mallette, Michael R. Strunk, Jerry Chang, Siddhesh R. Angle, David Kaplan

Article2015

Efficacy and safety of mesenchymal stromal cell therapy in preclinical animal models of sepsis

Lauralyn McIntyre, Manoj M. Lalu, Katrina Sullivan, Shirley H. J. Mei, David Moher, Dean Fergusson, Alexander T. Strauss, Duncan J. Stewart, Mazen Jasi, Malcolm Macleod, Brent W. Winston, John Marshall, Keith R. Walley

Article2017

Mesenchymal Stromal Cell Therapy in Bronchopulmonary Dysplasia: Systematic Review and Meta-Analysis of Preclinical Studies

Sajit Augustine, Marc T. Avey, Brittany Harrison, Tiffany Locke, Mona Ghannad, David Moher, Bernard Thébaud